Related by context. All words. (Click for frequent words.) 77 LOMUCIN TM 75 EVIZON TM 75 EVIZON 73 TELINTRA 73 EVIZON TM squalamine lactate 71 inflammatory autoimmune diseases 71 oral prodrug 70 alvespimycin 70 TRAIL receptor antibodies 70 Squalamine 69 ALN PCS 69 forodesine 69 synthetic retinoid 69 alpha interferons 69 CINTREDEKIN BESUDOTOX 69 prokinetic agent 68 acetonide FA 68 CYT# potent vascular disrupting 68 teduglutide 68 IL# PE 68 bevasiranib 68 catheter occlusion 67 MAXY G# 67 Zemiva ™ 67 LEP ETU 67 JAK inhibitor 67 investigational monoclonal antibody 67 CCX# 67 Fibrillex TM 67 rheumatoid arthritis thrombocytopenia 67 visilizumab 67 Zemiva TM 67 TKM ApoB 67 XP# XP# 67 OMNARIS HFA 67 PEG SN# 67 novel VDA molecule 67 incyclinide 67 lintuzumab SGN 67 SinuNase TM 67 RGB # 67 lomitapide 67 Thalomid ® 66 Solazed TM 66 thalidomide Thalomid 66 receptor tyrosine kinase inhibitor 66 AMEVIVE 66 neovascular 66 YONDELIS 66 verteporfin 66 oral methylnaltrexone 66 phase IIb clinical 66 Androxal TM 66 Xanafide 66 RELOVAIR ™ 66 HuLuc# 66 Central Retinal Vein 66 elotuzumab 66 TRIOLEX HE# APOPTONE HE# 66 octreotide implant 66 iSONEP 66 huC# DM4 66 CORT # 66 Cleviprex TM clevidipine 66 CORLUX CORT # 66 TACI Ig 66 Bezielle 66 Tß4 66 gastrointestinal disorders ATI 66 Zenvia ™ 65 Behcet uveitis 65 tramiprosate Alzhemed TM 65 induced macular edema 65 sargramostim 65 myeloproliferative diseases 65 severe hypercholesterolemia 65 fosbretabulin 65 choroidal neovascularization 65 pegaptanib 65 volociximab 65 docetaxel Taxotere ® 65 systemically administered 65 SPRYCEL ® 65 riociguat 65 urocortin 2 65 ISTODAX 65 TG# [003] 65 Intravitreal injections 65 IL# PE#QQR 65 Troxatyl 65 Phase IIb clinical trials 65 dirucotide 65 anti angiogenic agents 65 PLK1 SNALP 65 nalbuphine ER 65 CIMZIA R 65 potassium sparing diuretics 65 MKC# MT 65 PDE4 inhibitor 65 refractory gout 65 EVIZON ™ 65 targeted radiotherapeutic 65 Genasense ® oblimersen 65 Capesaris 65 evaluating satraplatin 65 alagebrium 65 RNAi therapeutic targeting PCSK9 65 kidney urologic 65 Dacogen injection 65 opioid induced bowel dysfunction 65 Panzem R NCD 65 alkylating agent 65 DEB# 65 CD# CEA 65 methylnaltrexone 65 dextromethorphan quinidine 65 Ophena TM 65 TNF alpha antagonist 65 AGILECT R 65 brivaracetam 65 Exelixis compounds 65 Phase III Pivotal 65 VEGF inhibitors 65 Onalta ™ 65 Phase IIa trials 65 relapsed MM 65 Mesafem 65 cMET 65 HQK 65 Lenocta 65 endothelin receptor antagonists 65 PROMACTA 65 INCB# [003] 65 OvaRex ® MAb 65 MAXY alpha 65 erlotinib Tarceva ® 65 Saforis 65 paclitaxel Taxol ® 64 pomalidomide 64 Xcytrin R 64 AQ4N 64 Triolex 64 INCB# [001] 64 efalizumab 64 MAGE A3 ASCI 64 OHR/AVR# 64 ASONEP 64 HDAC Inhibitor 64 gefitinib Iressa 64 cilengitide 64 Microplasmin 64 HGS ETR1 64 Tarceva TM 64 sorafenib tablets 64 pradefovir 64 severe hypersensitivity reactions 64 ThermoDox R 64 Motesanib 64 PXD# 64 interferon gamma 1b 64 ALN HPN 64 ocular formulation 64 orally administered inhibitor 64 Canvaxin TM 64 PEGINTRON TM 64 ENMD # 64 VEGF Trap 64 LibiGel ® 64 acyclovir Lauriad R 64 Tasimelteon 64 lenalidomide Revlimid R 64 oncolytic virus therapies 64 hypoxia activated prodrug 64 Anti VEGF 64 lapatinib Tykerb 64 Archexin 64 fluvastatin Lescol 64 torsemide ER 64 Alzhemed TM 64 AzaSite Plus 64 LEUKINE 64 tafamidis 64 EMSAM 64 PHX# 64 haematologic 64 phase IIb trial 64 TBC# 64 #D#C# 64 Phase IIIb clinical 64 menadione 64 alfa 2a 64 neovascular diseases 64 TLK# 64 PRT# 64 Ozarelix 64 Immunotherapeutic 64 Spiegelmer ® 64 cysteamine bitartrate 64 LymphoStat B TM 64 PrevOnco ™ 64 Telik logo TELINTRA 64 ZOLINZA 64 Panzem R 64 non nucleoside HCV 64 Insulin PH# 64 R sorafenib tablets 64 custirsen 64 Begins Dosing 64 Allovectin 7 R 64 refractory chronic lymphocytic 64 R#/MEM 64 Prestara 64 ocrelizumab 64 TELCYTA 64 6R BH4 64 dopaminergic therapy 64 Generx TM 64 dacetuzumab 64 Phase #b/#a clinical 64 ELND# 64 Certolizumab 64 hormone LHRH antagonist 64 trastuzumab DM1 T DM1 64 Proellex TM 64 Optiquel ™ 64 severe dermatologic toxicities 64 aldehyde dehydrogenase ALDH2 deficiency 64 immunomodulatory therapy 64 erlotinib Tarceva 64 Prolacria 64 Asentar 64 Zybrestat 64 PANVAC VF 64 ALN TTR# 64 HepeX B 64 oral nucleoside analogue 64 Perforomist ™ Inhalation Solution 64 Pimavanserin 64 talactoferrin 64 refractory angina 64 Liprotamase 63 motesanib 63 antiangiogenic agents 63 demonstrated antitumor activity 63 PREOS R 63 PS# [001] 63 neratinib 63 RNAi therapeutic targeting 63 telaprevir VX 63 MCSP respectively 63 intranasal formulation 63 goserelin 63 Octreolin 63 ruboxistaurin 63 PNP inhibitor 63 trastuzumab Herceptin ® 63 VAPRISOL 63 rhIGF-I/rhIGFBP-3 63 vidofludimus 63 docetaxel Taxotere R 63 omecamtiv mecarbil 63 r hGH 63 Phase Ib clinical 63 R Saizen R 63 R lenalidomide 63 metaglidasen 63 efaproxiral 63 candidate XP# 63 MyVax R 63 intensive lipid lowering 63 hyperphenylalaninemia HPA due 63 ocular inflammatory 63 skeletal muscle weakness 63 ALN TTR 63 SILENOR 63 mertansine 63 gastro intestinal inflammation 63 CTAP# Capsules 63 Phenoptin 63 ThermoDox ® clinical 63 sitaxsentan 63 SonoLysis 63 Insegia 63 SinuNase ™ 63 LHRH antagonists 63 selective modulator 63 dorzolamide 63 Tezampanel 63 rNAPc2 63 tezampanel NGX# 63 Aryplase 63 AZILECT R 63 budesonide foam 63 CIMZIA ™ 63 benign prostatic hypertrophy BPH 63 Marqibo TM 63 hoFH 63 BAY #-# 63 weekly subcutaneous injections 63 Cloretazine 63 E2F Decoy 63 ostarine 63 CEQ# 63 torcetrapib atorvastatin 63 Hepatocellular Carcinoma HCC 63 keloid scarring 63 homozygous familial hypercholesterolemia 63 AERx ® 63 RSD# oral 63 EDEMA3 trial 63 JAK inhibitors 63 Phase 2a trial 63 bortezomib Velcade 63 geographic atrophy 63 neovascular age 63 HGS ETR1 mapatumumab 63 hypereosinophilic syndrome 63 vaginally administered lidocaine 63 HCV protease inhibitors 63 R#/MEM # 63 Phase #b/#a trial 63 MGd 63 cediranib 63 senicapoc 63 SomatoKine 63 unresectable tumors 63 GALNS 63 FOLFOX chemotherapy 63 Dasatinib 63 Aflibercept 63 dirucotide MBP# 63 Starlix 63 rilonacept 63 selective androgen receptor modulator 63 Peginterferon alfa 2b 63 treat dysmenorrhea 63 Investigational Treatment 63 Abiraterone acetate 63 MYCAMINE 63 REMOXY R 63 Seliciclib 63 Prodarsan R 63 Bendavia 63 idiopathic thrombocytopenic purpura ITP 63 Evoltra ® 63 diabetic retinopathy DR 63 herpetic keratitis 63 ularitide 63 MEK inhibitors 63 molecular imaging radiopharmaceutical 63 SIRT1 activators 63 esophageal candidiasis 63 EGFRIs 63 Completes Patient Enrollment 63 Cimzia TM 63 corticosteroid dexamethasone 63 retinal vein occlusion induced 63 PEGPH# 63 INS# [001] 63 NAGS deficiency 63 nonclinical studies 63 Dupuytren Disease 63 myelofibrosis polycythemia vera 63 MEK inhibitor 63 investigational protease inhibitor 63 iSONEP TM 63 thrombolytic agent 63 ADP receptor antagonist 63 P#X# antagonist 63 Silodosin 63 CR# vcMMAE 63 pouchitis 63 tolevamer 63 Cetrorelix 63 octreotide acetate 63 midstage trials 63 ancrod 63 cisplatin gemcitabine 63 Actimmune ® 63 enzastaurin 63 punctal plug 63 Altastaph 63 IMiDs 63 cannabinor 63 BLA filing 63 gamma secretase inhibitor 63 PI3K/Akt pathway inhibitor 63 ZOMETA 63 Bevasiranib 63 Orally administered 63 Initiates Clinical Trial 63 telomerase therapeutic 63 Severe hypersensitivity reactions 63 lenalidomide dexamethasone 63 samarium Sm 63 Personalized Immunotherapy 63 HGS ETR2 63 retinal vein occlusion RVO 63 lumiliximab 62 anthracycline unless 62 immunological diseases 62 Urocortin 2 62 pediatric malignancies 62 ONCONASE R 62 mixed hyperlipidemia 62 renoprotective 62 rALLy 62 PSN# [002] 62 HCD# [002] 62 Telintra 62 diabetic kidney 62 Xyfid TM 62 Interferon alpha 62 tremelimumab 62 posterior uveitis 62 Eraxis 62 XL# XL# XL# XL# 62 DMARDS 62 QLT# 62 TNF antagonist 62 PROSTVAC VF 62 Tolvaptan 62 GW# [003] 62 Mipomersen 62 Trofex TM 62 sodium Injection 62 diabetic macular edema 62 ONTAK 62 axitinib 62 ruxolitinib 62 Aurora kinase inhibitor 62 lexidronam injection 62 venlafaxine Effexor 62 fenretinide 62 nitazoxanide 62 paclitaxel Taxol 62 Solazed ™ 62 anemia neutropenia 62 myopathy rhabdomyolysis 62 ALN HTT 62 EXJADE 62 ganetespib 62 tanespimycin 62 inhibitor RG# 62 induce remission 62 CA4P 62 dasatinib Sprycel ® 62 EGFR HER2 62 aspirin clopidogrel 62 Hedgehog antagonist 62 Onconase 62 Specifid 62 ISIS # 62 #beta HSD1 62 recurrent glioblastoma multiforme 62 sodium thiosulfate STS 62 LUCENTIS 62 INTEGRILIN 62 anthracyclines taxanes 62 Geron telomerase inhibitor 62 ACTEMRA TM 62 celgosivir 62 AKT inhibitor 62 vitamin B# folic acid 62 Virulizin ® 62 candidate CRLX# 62 generation purine nucleoside 62 Allovectin 7 62 anthracycline chemotherapy 62 nucleotide analog 62 MEK Inhibitor 62 Zolinza 62 FOLOTYN ® 62 EDARBI 62 GSK# [001] 62 acute GvHD 62 PDE# inhibitors 62 trastuzumab Herceptin R 62 EOquin 62 TOCOSOL Paclitaxel 62 hematological indications 62 Phase 1b clinical trials 62 sunitinib malate 62 LPM TM 62 concomitant medications 62 carcinoid syndrome 62 novel emulsion formulation 62 QUADRAMET R 62 induced anemia 62 lintuzumab 62 Vfend 62 exocrine pancreatic insufficiency EPI 62 proliferative diabetic retinopathy 62 calcineurin inhibitor 62 Pivotal Phase III 62 5 lipoxygenase inhibitor 62 posaconazole 62 Dapagliflozin 62 faropenem 62 PEG uricase 62 Asentar TM 62 successfully commercialize Iluvien 62 ELACYT 62 Kepivance 62 tasimelteon 62 serum uric acid sUA 62 brand ciclesonide HFA 62 choroidal neovascularization CNV 62 anti angiogenic agent 62 class mGluR5 inhibitor 62 ATACAND 62 Selective Electrochemical Tumor Ablation 62 GAMMAGARD 62 latrepirdine 62 Diabetic Macular Edema 62 CIMZIA TM 62 GnRH antagonist 62 ocular disorders 62 post herpetic neuralgia PHN 62 THR beta agonist 62 Trofex 62 LymphoStat B belimumab 62 Vidaza ® 62 highly selective inhibitor 62 mTOR inhibition 62 aflibercept VEGF Trap 62 intravitreal injection 62 pain palliation 62 Navelbine ® 62 Anturol TM 62 Entereg R 62 evaluating mipomersen 62 RELISTOR ® 62 CDP# 62 nucleoside analogues 62 Plicera 62 Phase Ib study 62 mGluR2 NAM 62 atacicept 62 gastrointestinal disorders characterized 62 Soriatane 62 AzaSite TM 62 TLR9 agonists 62 PSMA ADC 62 sunitinib Sutent 62 regorafenib 62 MKC# MKC# PP 62 Vidaza azacitidine 62 TÎ ² 4 62 maximally tolerated lipid lowering 62 Pyridorin 62 mGluR5 NAM 62 exudative 62 Panzem 62 HuMax EGFr 62 BXT # 62 Phase IIa clinical trials 62 transthyretin mediated amyloidosis ATTR 62 candidates Azedra TM 62 HMG CoA reductase inhibitors 62 plasma kallikrein inhibitor 62 psoriasis rheumatoid arthritis 62 Revimmune 62 HGS# 62 SUPPRELIN R LA 62 diarrhea predominant irritable 62 diabetic macular edema DME 62 Solazed 62 Nexavar sorafenib 62 GVAX ® 62 GnRH agonists 62 dimebon latrepirdine 62 ADVEXIN clinical 62 secondary amenorrhea 62 deforolimus 62 skeletal metastases 62 Triapine R 62 TOLAMBA 62 sapropterin dihydrochloride Tablets 62 symptomatic hyponatremia 62 VP# [004] 62 Noxafil 62 anthracycline taxane 62 Granulocyte Colony Stimulating Factor 62 Tekamlo 62 Teriflunomide 62 systemic RNAi therapeutic 62 PDX pralatrexate 62 Traficet EN 62 Phase 2b Trial 62 Zelapar 62 eltrombopag 62 subcutaneous formulation 62 urate lowering 62 ALVESCO HFA 62 IMC #B 62 thrombolytic agents 62 telomerase inhibitor drug 62 EGS# 62 SARMs 62 RhuDex 62 Phase Ib clinical trials 62 terlipressin 62 Targretin capsules 62 Prosaptide 62 dexanabinol 62 ALN VSP 62 pioglitazone HCl 62 immunosuppressant drug 62 PEGylated interferon 62 immune modulating 62 INSPIRE Trial Phase III 62 denufosol tetrasodium 62 corticosteroid therapy 62 investigational humanized monoclonal antibody 62 LOVENOX R 62 leukemia AML 62 pharmacodynamic parameters 62 virus HCV protease inhibitor 62 ospemifene 62 Vascugel 62 dexpramipexole 62 Symadex 62 oral JAK1 62 liposomal formulation 62 NATRECOR ® 62 Alinia 62 Cinquil 62 recurrent glioblastoma 62 GRNCM1 62 ATL# [001] 62 Pafuramidine 62 Civacir 62 TH# [003] 62 PDE4 inhibitors 62 metastatic castration resistant 62 prophylactic therapy 62 preclinical pharmacokinetic 62 cell lymphoma CTCL 62 INFERGEN 62 dosage regimens 62 LAF# 61 MAXY VII 61 Zorbtive TM 61 immunomodulation 61 aurora kinase 61 hematologic disorders 61 www.telik.com 61 Phenserine 61 KNS # 61 Hedgehog Pathway Inhibitor 61 danoprevir 61 secondary hyperparathyroidism 61 p# MAP kinase inhibitor 61 Aviptadil 61 Icatibant 61 multitargeted 61 GED aPC 61 eprotirome 61 Allovectin 7 ® 61 Darapladib 61 candidate TNFerade biologic 61 COPEGUS R 61 SUTENT ® 61 dosing cohort 61 Achieves Primary Endpoint 61 biologic DMARD 61 prostone 61 AAG geldanamycin analog 61 metformin accumulation 61 GLP1 agonist 61 Ceplene/IL-2 61 GTC recombinant human 61 panitumumab Vectibix 61 confirmatory Phase III 61 #I TM# 61 glucagon receptor 61 oral calcitonin 61 THALOMID 61 Pivotal Phase 61 GnRH antagonists 61 tizanidine hydrochloride short 61 bardoxolone 61 familial hypercholesterolemia FH 61 aplindore 61 TORISEL 61 docetaxel chemotherapy 61 alemtuzumab Campath 61 Fludara ® 61 oxymorphone ER 61 ANAVEX #-# [001] 61 R rilonacept Injection 61 drug GAP #B# 61 randomized #:#:# 61 Gliadel Wafer 61 proteasome inhibitor 61 Sutent sunitinib 61 Certolizumab pegol 61 PORxin TM platforms 61 TREDAPTIVE 61 levodopa carbidopa 61 intravenous immunoglobulin IVIg 61 AVE# 61 HCV protease inhibitor 61 iobenguane 61 Phase 2b Clinical Trial 61 APTIVUS 61 Enzastaurin 61 alemtuzumab MS 61 Elagolix 61 neovascular AMD 61 Phase #b/#a 61 ELADUR ™ 61 delivers fluocinolone acetonide FA 61 Shigamabs ® 61 paclitaxel Taxol R 61 oral talactoferrin 61 recurrent NSCLC 61 omega interferon 61 PEG PAL 61 aerosolized AAT 61 rheumatoid arthritis multiple sclerosis 61 cromolyn sodium 61 MYLOTARG 61 Bicifadine 61 metastatic hormone refractory 61 vismodegib 61 Diamyd ® 61 Hedgehog pathway inhibitor 61 cytopenias 61 drug ISA# 61 taxane chemotherapy 61 Alfimeprase 61 Crizotinib 61 Phase 2a Clinical Trial 61 Azedra 61 TOCOSOL Camptothecin 61 Platinol ® cisplatin 61 baminercept 61 Safinamide 61 Meets Primary Endpoint 61 predominantly classic subfoveal 61 interferon therapy 61 HBeAg negative 61 Romidepsin 61 FUSILEV enhances 61 products MKC# PP 61 RAPTIVA R 61 either acutely decompensated 61 Initiates Phase II 61 serum phosphorous 61 Cand5 61 Phase 2a clinical trials 61 investigational compounds 61 Rilonacept 61 pentostatin 61 Dextofisopam 61 BrachySil TM 61 Urocidin TM 61 Dacogen decitabine 61 DCCR 61 neutropenic patients 61 Canvaxin 61 headache nasopharyngitis 61 ATPace TM 61 APTIVUS r 61 rufinamide 61 anticlotting drugs 61 cobiprostone 61 lucinactant 61 ZACTIMA 61 oropharyngeal candidiasis OPC 61 reslizumab 61 receptor inhibitor 61 Cancidas 61 fostamatinib 61 Raptiva ® 61 cicletanine 61 conventional DMARDs 61 Phase IIB 61 investigational therapies 61 Friedreich Ataxia FRDA 61 anticancer compound 61 TYZEKA 61 KAPIDEX 61 NP2 Enkephalin 61 Neo Kidney Augment 61 vascular disrupting agents 61 HoFH 61 lesinurad 61 Azedra TM Onalta TM 61 Forodesine HCl 61 naronapride 61 beta 1a 61 K ras mutations 61 hepatotoxicity 61 UPLYSO 61 Pruvel 61 anticholinergic agents 61 Decitabine 61 GSK # 61 Gleevec imatinib mesylate 61 Amplimexon 61 CDK cyclin dependent 61 relapsing remitting MS RRMS 61 liver transaminases 61 CDAD Clostridium difficile 61 Aurexis 61 colesevelam HCl 61 LAB CGRP 61 oral leukoplakia 61 metastatic malignant 61 Reports Preclinical Data 61 Cintredekin Besudotox 61 myelodysplastic syndromes MDS 61 HuMax CD4 61 interferon alpha IFN 61 pegylated interferons 61 Atrasentan 61 ORENCIA R 61 ® lenalidomide 61 Neovascular 61 Protexia ® 61 fenofibric acid 61 kallikrein 61 Glufosfamide 61 Velcade bortezomib 61 Cytarabine 61 Cethrin 61 cetuximab Erbitux R 61 Degarelix 61 Lixivaptan 61 Factor VIIa 61 JAK2 Inhibitor 61 superficial bladder cancer 61 Pemetrexed 61 Perceiva 61 liposomal formulations 61 antibody MAb 61 methylnaltrexone bromide 61 Catena ® 61 renal flares 61 oral salmon calcitonin 61 TRISENOX ® 61 Methylnaltrexone 61 Oxypurinol 61 trastuzumab DM1 61 sorafenib Nexavar 61 JAK1 61 NeuroSTAT ® 61 Cellegesic 61 IAP inhibitor 61 prescribed proton pump 61 VELCADE melphalan 61 DR Cysteamine 61 mitoxantrone plus 61 Arranon 61 Neurodex 61 Prodarsan ® 61 immunotherapeutic approaches 61 midstage clinical 61 Preclinical studies suggest 61 samalizumab 61 Spheramine 61 Alequel 61 BiovaxID TM 61 vaginal candidiasis 61 XL# SAR# 61 Phase #/#a trial 61 novel oral anticoagulant 61 POSIDUR TM ELADUR TM 61 glucokinase activator 61 Phase IIb trials 61 Platinol ® 61 complement inhibitor eculizumab 61 hypoparathyroidism 61 Enbrel Humira 61 serotonin norepinephrine reuptake inhibitor 61 Curaxin CBLC# 61 immuno modulatory 61 MMP inhibitors 61 clevidipine 61 oral picoplatin 61 small molecule tyrosine 61 TLR9 agonist 61 PEGylated Fab fragment 61 cancer neuroendocrine tumor 61 benign prostatic hypertrophy 61 Clolar ® 61 cancer immunotherapies 61 Protexia R 61 EOquin TM 61 Ribavirin causes 61 Itopride 61 Iluvien ® 61 CYT# QbG# 61 maribavir 61 valopicitabine 61 sJIA 61 bardoxolone methyl 61 autoimmune uveitis 61 GERD migraine headaches 61 ocular diseases 61 HepeX B TM 61 BENLYSTA ® 61 tramiprosate ALZHEMED TM 61 LNP formulations 61 CRLX# 61 adalimumab Humira 61 ATL/TV# 61 AEG# 61 JZP 61 acitretin 61 ocular inflammation 61 olmesartan 61 Cloretazine VNP#M 61 Extina 61 certolizumab 61 Neulasta ® 61 Diabetic Neuropathy 61 cinacalcet HCl 61 Interferon beta 1a 61 briakinumab 61 levodopa therapy 61 PREZISTA r 61 HDL Selective Delipidation 61 Amrubicin 61 BEMA Granisetron 61 Besivance 61 Laquinimod 61 including eniluracil ADH 61 ® decitabine 61 pharmacological approaches 61 phase IIa 61 therapeutic regimens 61 Octreotide 61 palifermin 61 APEX PD 61 SYN# 61 ARIKACE ™ 61 KAPVAY ™ 61 trial evaluating PRX# 61 oral antidiabetic medication 61 oxidative stress inducer 61 Oracea TM 61 Nuvion 61 inhibit platelet function 61 ACAPODENE 61 Denufosol 61 BRIM2 60 renal toxicity 60 calcitonin 60 Vandetanib 60 Muraglitazar 60 plasma pharmacokinetics 60 choroidal vasculopathy 60 E1 INT TM 60 HYVISC R 60 mTOR inhibitors 60 Viprinex 60 ALVESCO R 60 Natalizumab 60 sirtuin inhibitor program 60 IV APAP 60 RhuDex R 60 vaccines oncolytic virus 60 cintredekin besudotox 60 coadministration 60 MYDICAR 60 erythropoietic 60 DURIN TM 60 Golimumab 60 nucleoside analog 60 novel histone deacetylase 60 leukotriene receptor antagonist 60 danazol 60 Viramidine 60 Glypromate 60 postoperative ileus 60 histone deacetylase HDAC inhibitor 60 ALVESCO ® 60 Cytogen marketed 60 Corlux 60 oxypurinol 60 Tanespimycin 60 vaccine GRNVAC1 60 Initiates Phase III 60 relapsed leukemia 60 PEGylated anti 60 anti CD3 antibody 60 pemphigus vulgaris 60 targeting PCSK9 60 vaginal lidocaine 60 proliferative retinopathy 60 ara C 60 multi kinase inhibitor 60 UVIDEM 60 lipid lowering agents 60 OMNARIS Nasal Spray